Choline C 11 (Washington University School of Medicine)


Welcome to the PulseAid listing for the Choline C 11 drug offered from Washington University School of Medicine. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Washington University School of Medicine
NON-PROPRIETARY NAME: Choline C-11
SUBSTANCE NAME: CHOLINE C-11
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-01-10
END MARKETING DATE: 0000-00-00


Choline C 11 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCholine C 11 from Washington University School of Medicine
LABELER NAME: Washington University School of Medicine
DEA SCHEDULE:
ACTIVE STRENGTH: 33.1(mCi/mL)
START MARKETING DATE: 2017-01-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 75913-311_1c0a2b3e-a632-40b2-b87d-f8134ab37d85
PRODUCT NDC: 75913-311
APPLICATION NUMBER: ANDA208413

Other CHOLINE C-11 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Global Isotopes, LLC d/b/a Zevacor MolecularCholine C 11
Mayo ClinicCholine C 11
Precision Nuclear LLCCholine C 11
The University of Texas MD Anderson Cancer CenterCholine C 11
Washington University School of MedicineCholine C 11